Basic and Clinical Neuroscience، جلد ۱۶، شماره ۳، صفحات ۰-۰

عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله

عنوان انگلیسی Vismodegib Improved Therapy of Medulloblastoma by Targeting Sonic Hedgehog Signaling Pathway on DAOY Medulloblastoma Cell Line
چکیده انگلیسی مقاله
Introduction: Targeting SMO has been a remarkable strategy in Shh-dependent cancers, especially medulloblastoma. In this manner, GDC-0449 or vismodegib is used as a potent SMO inhibitor with mild toxicity and high affinity. Thus, the main purpose of the present study was to investigate the anti-medulloblastoma efficacy of vismodegib on the DAOY medulloblastoma cell line.
Methods: Human DAOY medulloblastoma cells were cultured in DMEM.50, 80, 100, and 150μM doses of vismodegib were used to treat cells. MTT, Scratch, and trypan blue assay, and also real-time polymerase chain reaction (RT-PCR) and immunofluorescence studies were performed, 24 and 48 hours post-treatment.
Results: MTT and trypan blue assay showed a significant difference in viability, between the control group and treatment groups. Results of the scratch assay showed that in the control group, the cells managed to repair the lesion, while the scratch was disintegrated in higher doses of vismodegib. The expression of SMO, Gli1, and MYCN genes, as the main components of the SHH signaling pathway, had a significant reduction in the vismodegib-treated groups compared to the control group. Also a notable rise in the activation of metastasis-promoting genes (Bax and p53) while a reduction in metastasis-inhibiting gene (Bcl2), was observed.
Conclusion: The results of the current study confirm that vismodegib is a potent inhibitor of the Shh pathway and could be used as a drug in combination with new therapeutic methods, in order to treat medulloblastoma.
کلیدواژه‌های انگلیسی مقاله Vismodegib, Drug therapy, Medulloblastoma, Neoplasm, Toxicity

نویسندگان مقاله | Masume Behruzi
Department of Anatomical Sciences, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.


| Mehrdad Ghorbanlou
Department of Anatomical Sciences, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.


| Ronak Shabani
Department of Anatomical Sciences, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.


| Auob Rustamzadeh
Department of Anatomy, School of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.


| Enam Alhagh Charkhat Gorgich
Department of Anatomy, School of Medicine, Iranshahr University of Medical Sciences, Iranshahr, Iran.


| Elham Seidkhani
Department of Anatomical Sciences, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.


| Farnoosh Usefi
Department of Anatomical Sciences, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.


| Mehdi Mehdizadeh
Department of Anatomical Sciences, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran.


| Fatemeh Moradi
Department of Anatomical Sciences, Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran



نشانی اینترنتی http://bcn.iums.ac.ir/browse.php?a_code=A-10-6423-1&slc_lang=en&sid=1
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده Cellular and molecular Neuroscience
نوع مقاله منتشر شده Original
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات